SCHEMBL18830089

SCHEMBL18830089

CC(C)n1nnc2cnc(Cl)nc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 1/20 0.39
▸ CYP1A2 P05177 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ DYRK1A Q13627 3/20 0.35
▸ ATM Q13315 2/20 0.35
▸ CLK1 P49759 2/20 0.35
▸ CCNA2 P20248 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ CCNA1 P78396 1/20 0.33
▸ CDK5 Q00535 1/20 0.33
▸ CDK5R1 Q15078 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ HCAR3 P49019 1/20 0.33
▸ HCAR2 Q8TDS4 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ RPS6KA5 O75582 2/20 0.31
▸ TOP2A P11388 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19416674 0.84 MET (0.36) METALDH1A1SMN1; SMN2KDM4E
SCHEMBL6203819 0.79 ALDH1A1 (0.36) CYP1A2CYP2C19ALDH1A1SMN1; SMN2DYRK1A
SCHEMBL31364861 0.78 CLK1 (0.38) METDYRK1AATMCLK1
SCHEMBL31531609 0.78 CLK1 (0.38) METDYRK1AATMCLK1
SCHEMBL31364948 0.78 MET (0.36) METDYRK1AATMCLK1
SCHEMBL31364793 0.77 CCR4 (0.45) MET
SCHEMBL31364985 0.77 MET (0.42) METCYP1A2CYP2C19ALDH1A1SMN1; SMN2
SCHEMBL23507945 0.77 ALDH1A1 (0.34) CYP1A2CYP2C19ALDH1A1SMN1; SMN2DYRK1A
SCHEMBL16022043 0.77 MET (0.45) METALDH1A1SMN1; SMN2DYRK1AATM
SCHEMBL20251286 0.74 ALDH1A1 (0.33) CYP1A2CYP2C19ALDH1A1SMN1; SMN2DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964649-B1 TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER MERCK PATENT GMBH (DE) 2017-05-10 — — EP disclosed
Send feedback